Skip to main content
Log in

Presence of an H+/Quinidine Antiport System in Madin–Darby Canine Kidney Cells

  • Original Research Article
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Abstract

Background and Objectives

We have recently found an H+/quinidine antiport system in human kidney HEK 293 cells. The aim of the present study was to evaluate whether the H+/quinidine antiport system is expressed in Madin–Darby canine kidney (MDCK) cells.

Methods

We investigated the uptake and efflux of quinidine in MDCK cells.

Results

The uptake of 100 µM quinidine into MDCK cells was decreased by acidification of extracellular pH or alkalization of intracellular pH. In addition, the uptake of quinidine was highly temperature sensitive, but was extracellular Na+ and membrane potential independent. Furthermore, tetraethylammonium, a typical substrate of renal organic cation transporters, did not inhibit the uptake of quinidine in MDCK cells. On the other hand, lipophilic cationic drugs, such as clonidine, bisoprolol, diphenhydramine, pyrilamine, and imipramine, significantly decreased the uptake of quinidine in MDCK cells. The uptake of quinidine was saturable, and the Michaelis–Menten constant was estimated to be approximately 0.5 mM. In addition, the efflux of quinidine from MDCK cells was increased by the acidification of extracellular pH, suggesting that the transport system mediates not only the uptake, but also secretion of quinidine.

Conclusions

The present findings suggested that the renal new antiport system is involved in the bidirectional membrane transport of quinidine in MDCK cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 2007;24:1227–51.

    Article  CAS  PubMed  Google Scholar 

  2. Motohashi H, Inui K. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney. AAPS J. 2013;15:581–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Tahara K, Kagawa Y, Takaai M, Taguchi M, Hashimoto Y. Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells. Drug Metab Pharmacokinet. 2008;23:340–6.

    Article  CAS  PubMed  Google Scholar 

  4. Masago M, Takaai M, Sakata J, Horie A, Ito T, Ishida K, Taguchi M, Hashimoto Y. Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells. Biol Pharm Bull. 2010;33:1407–12.

    Article  CAS  PubMed  Google Scholar 

  5. Horie A, Ishida K, Shibata K, Taguchi M, Ozawa A, Hirono K, Ichida F, Hashimoto Y. Pharmacokinetic variability of flecainide in younger Japanese patients and mechanisms for renal excretion and intestinal absorption. Biopharm Drug Dispos. 2014;35:145–53.

    Article  CAS  PubMed  Google Scholar 

  6. Horie A, Ishida K, Watanabe Y, Shibata K, Hashimoto Y. Membrane transport mechanisms of choline in human intestinal epithelial LS180 cells. Biopharm Drug Dispos. 2014;35:532–42.

    Article  CAS  PubMed  Google Scholar 

  7. Ishida K, Horie A, Nishimura M, Taguchi M, Fujii N, Nozawa T, Inoue H, Hashimoto Y. Variability of bioavailability and intestinal absorption characteristics of bisoprolol. Drug Metab Pharmacokinet. 2013;28:491–6.

    Article  CAS  PubMed  Google Scholar 

  8. Mizuuchi H, Katsura T, Saito H, Hashimoto Y, Inui KI. Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system. J Pharmacol Exp Ther. 1999;290:388–92.

    CAS  PubMed  Google Scholar 

  9. Jans AW, Amsler K, Griewel B, Kinne RK. Regulation of intracellular pH in LLC-PK1 cells studied using 31P-NMR spectroscopy. Biochim Biophys Acta. 1987;927:203–12.

    Article  CAS  PubMed  Google Scholar 

  10. Gerhardt RE, Knouss RF, Thyrum PT, Luchi RJ, Morris JJ Jr. Quinidine excretion in aciduria and alkaluria. Ann Intern Med. 1969;71:927–33.

    Article  CAS  PubMed  Google Scholar 

  11. Hertrampf R, Gundert-Remy U, Beckmann J, Hoppe U, Elsässer W, Stein H. Elimination of flecainide as a function of urinary flow rate and pH. Eur J Clin Pharmacol. 1991;41:61–3.

    Article  CAS  PubMed  Google Scholar 

  12. Freudenthaler S, Meineke I, Schreeb KH, Boakye E, Gundert-Remy U, Gleiter CH. Influence of urine pH and urinary flow on the renal excretion of memantine. Br J Clin Pharmacol. 1998;46:541–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yukiya Hashimoto.

Ethics declarations

Funding

This work was supported by JSPS KAKENHI Grant Number 15K08069.

Conflict of interest

MF, EK, HN, RH, AH and YH declare no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukao, M., Kondo, E., Nishino, H. et al. Presence of an H+/Quinidine Antiport System in Madin–Darby Canine Kidney Cells. Eur J Drug Metab Pharmacokinet 41, 819–824 (2016). https://doi.org/10.1007/s13318-015-0314-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-015-0314-1

Keywords

Navigation